Elanco Animal Health Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Elanco Animal Health Inc.
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.
Others were interested in
See all stocksFrequently asked questions
To buy Elanco Animal Health Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Elanco Animal Health Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Elanco Animal Health Inc. is ELAN:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Elanco Animal Health Inc. has its primary listing on New York Stock Exchange. You can trade Elanco Animal Health Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Elanco Animal Health Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Elanco Animal Health Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Elanco Animal Health Inc..